Home → Focus

FDA Approves Most Expensive Drug Ever Print E-mail
Written by FHI's Week in Review   
Monday, 27 May 2019 11:43

Rob Stein reports for NPR on a new drug developed by a subsidiary of Novartis, in a post dated May 24, 2019:
The federal Food and Drug Administration has approved a gene therapy for a rare childhood disorder that is now the most expensive drug on the market. It costs $2.125 million per patient. But for those patients lucky enough to get it, it appears it can save their lives with a one-time treatment...<The medication treats> spinal muscular atrophy (SMA), a rare disorder caused by a defective gene; the illness destroys the nerves that control muscles.
Read more in the current issue of Week in Review>>

Last Updated on Monday, 17 June 2019 12:02
DoD Wants to Impose CMPs on Those Who Defraud TRICARE Print E-mail
Written by Vitale Health Law   
Tuesday, 14 May 2019 12:04
Plagued by fraud and abuse targeting its TRICARE program, the U.S. Department of Defense, on May 1, issued a proposed rule that would allow it to impose civil monetary  penalties (CMPs) against providers and suppliers who commit fraud and abuse against the TRICARE program. The new rule would create the "Military Health Care Fraud and Abuse Prevention Program."

TRICARE is the federal healthcare program that provides benefits to the military, military retirees and their families. DoD says the authority is necessary because of the Department of Justice's limited resources to go after those who commit fraud against TRICARE.

Instead of re-inventing the wheel, DoD proposes to adopt "well-established CMP rules and procedures" used by the U.S. Department of Health and Human Services "to enable both TRICARE and TRICARE providers to rely upon Medicare precedents and guidance issued by the HHS Office of Inspector General (OIG) regarding conduct that implicates" the CMP law.
Read More

Last Updated on Tuesday, 14 May 2019 12:09
White House requires Big Pharma to list drug prices on TV ads as soon as this summer Print E-mail
Written by FHI's Week in Review   
Monday, 13 May 2019 18:20
Berkeley Lovelace, Jr. reports for CNBC on May 8, 2019:
Pharmaceutical companies will be required to disclose the price of its prescription medicines in television commercials, the Trump administration says. The requirement is set to take effect as soon as this summer and will apply to drugs that cost more than $35 for a month's supply. High drug costs have become a rare bipartisan issue with lawmakers on both sides of the aisle demanding something be done.
Read more in the current issue of Week in Review>>

Last Updated on Friday, 07 June 2019 16:38
Meth Vs. Opioids: America Has Two Drug Epidemics, but Focuses on One Print E-mail
Written by April Dembosky | KQED via KHN   
Thursday, 09 May 2019 00:00
While public health officials have focused on the opioid epidemic in recent years, another epidemic has been brewing quietly, but vigorously, behind the scenes.  Methamphetamine use is surging in parts of the U.S., particularly the West, leaving first responders and addiction treatment providers struggling to handle a rising need. Across the country, overdose deaths involving meth more than quadrupled from 2011 to 2017. Admissions to treatment facilities for meth are up 17%. Hospitalizations related to meth jumped by about 245% from 2008 to 2015. And throughout the West and Midwest, 70% of local law enforcement agencies say meth is their biggest drug threat. But policymakers in Washington, D.C., haven't kept up, continuing to direct the bulk of funding and attention to opioids, said Steve Shoptaw, an addiction psychologist at UCLA in Los Angeles, where he hears one story after another about meth destroying people's lives.
Last Updated on Friday, 10 May 2019 17:49
New Class A Medical Office Building Planned for Delray Beach Print E-mail
Written by FHInews   
Tuesday, 30 April 2019 00:00
Delray Beach, FL – Kenneth Weston Healthcare Real Estate and Azure Development today announce the development of Addison Medical Pavilion.

“There is a pent-up demand for medical space offering the newest and most advanced technology,” said Kenneth Weston, Chairman & CEO of Kenneth Weston Healthcare Real Estate, who is spearheading the developing and marketing of Addison Medical Pavilion. “Healthcare professionals looking for new Class A space will soon have the opportunity to locate in a new 24,000-square-feet medical building in Delray Beach, Florida.”

Catering to the needs of healthcare professionals, their staff and patients from its location at 16189 Jog Road, Delray Beach, the modern facility is ideal for a multi-specialty practice, ambulatory surgery center, imaging center, and other physician and dental offices. Situated at the corner of Linton Boulevard and Jog Road, approximately one mile West of Delray Medical Center, a Level 1 trauma facility that recently completed an $80,000,000 expansion, and just minutes from the Florida Turnpike and I-95, Addison Medical Pavilion will service some of the exclusive residential communities in south Palm Beach County including Addison Reserve, The Polo Club, St. Andrews, Boca West, and Woodfield Country Clubs.

Amenities include a 9:1,000 parking ratio, leading-edge technology and design elements, porte-cochere patient drop off area, state-of-the-art security system, two stretcher cab elevators, 12-foot ceiling heights, electrical and plumbing components designed to meet the demands of the most sophisticated surgical and diagnostic centers and other types of specialists. Additionally, elegant common area bathrooms on each floor will complement a two-story atrium lobby reflective of a residential type setting, also featuring tenant controlled A/C and electric.

To learn more about Addison Medical Pavilion, please contact Kenneth Healthcare Real Estate at (305) 279-2700 or

About Kenneth Weston Healthcare Real Estate
      Kenneth Weston Healthcare Real Estate has specialized in healthcare real estate and medical office space since 1978 and is considered today’s foremost expert in the development, leasing, and sales of medical office buildings in South Florida.
      The firm has been involved in more than 15 million square feet of medical office space and is uniquely qualified in understanding local nuances of healthcare design and development, tenant mix and physician/patient interplay vital to ensure successful healthcare projects. Additionally, knowledge of specific markets, while keeping a perspective of the greater South Florida area, has healthcare providers and investors seeking Kenneth Weston’s vast experience, local expertise, and savvy in determining a project’s viability.
About Azure Development
Azure Development is a Delray Beach-based real estate development company with extensive experience in all aspects of real estate including commercial and medical office building development. The company is known for its attention to detail, exceptional design, and superior craftsmanship.

Last Updated on Friday, 03 May 2019 11:40
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 4 of 139

Website design, development, and hosting provided by